tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market
NURPF
Neuren Pharmaceuticals Limited
RESEARCH TOOLSreports

Neuren Pharmaceuticals Limited (NURPF) Income Statement

56 Followers

Neuren Pharmaceuticals Limited Income Statement

Last quarter (Q4 2025), Neuren Pharmaceuticals Limited's total revenue was AU$36.36M, a decrease of -78.49% from the same quarter last year. In Q4, Neuren Pharmaceuticals Limited's net income was AU$15.40M. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 64.63MAU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20M
Gross Profit
AU$ 64.61MAU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19M
Operating Expenses
AU$ 42.59MAU$ 37.67MAU$ 32.70MAU$ 16.14MAU$ 11.42M
Depreciation and Amortization
AU$ 23.00KAU$ 22.00KAU$ 17.00KAU$ 10.00KAU$ 8.00K
EBITDA
AU$ 22.05MAU$ 175.57MAU$ 199.26MAU$ -670.00KAU$ -10.98M
Operating Income
AU$ 22.02MAU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43M
Other Income/Expenses
AU$ 16.91MAU$ 7.39MAU$ 32.65MAU$ 916.00KAU$ 439.00K
Pretax Income
AU$ 38.93MAU$ 182.94MAU$ 205.14MAU$ -680.00KAU$ -10.99M
Net Income
AU$ 30.44MAU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79M
Per Share Metrics
Basic EPS
AU$ 0.24AU$ 1.09AU$ 1.24AU$ 0.00AU$ -0.07
Diluted EPS
AU$ 0.23AU$ 1.09AU$ 1.20AU$ 0.00AU$ -0.07
Weighted Average Shares Outstanding
 128.24M 127.77M 127.07M 125.97M 117.77M
Weighted Average Shares Outstanding (Diluted)
 130.77M 130.78M 130.77M 128.91M 117.77M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History